Market capitalization of Aptose Biosciences (APTO)

Market cap: NZ$11.05 Million

As of October 2024 Aptose Biosciences has a market cap of NZ$11.05 Million. This makes Aptose Biosciences the world's 9806th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

End of year Market Cap

End of Day market cap according to different sources

On Oct 15th, 2024 the market cap of Aptose Biosciences was reported to be:

NZ$10.77 Million

by Yahoo Finance

NZ$10.77 Million

by CompaniesMarketCap

NZ$11.02 Million

by Nasdaq

Market capitalization for similar companies or competitors

Name	Marketcap	Market cap differencediff.	Country
Advaxis ADXS	NZ$1.89 M	-82.83%	🇺🇸 USA
Corbus Pharmaceuticals CRBP	NZ$0.38 B	3,339.96%	🇺🇸 USA
ImmunoGen IMGN	NZ$14.39 B	130,156.11%	🇺🇸 USA